Akanda (AKAN) Total Current Liabilities (2020 - 2025)
Akanda's (AKAN) quarterly Total Current Liabilities came in at $6.2 million in Q4 2025, up 70.43% year-on-year from $3.6 million in Q4 2024, and up 118.06% quarter-over-quarter from $2.8 million in Q2 2025.
Akanda (AKAN) Total Current Liabilities (2020 - 2025) Analysis & Trends
Akanda's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $6.2 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities rose 70.43% year-over-year to $6.2 million in Q4 2025; TTM through Dec 2025 was $6.2 million, a 70.43% increase from a year earlier, with the FY2025 full-year figure at $6.2 million, up 70.43% from the prior year.
- Total Current Liabilities grew to $6.2 million in Q4 2025 per AKAN's latest filing, from $2.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $12.4 million in Q2 2023 and bottomed at $2.8 million in Q2 2025.
- The 5-year median for Total Current Liabilities is $6.3 million (2022), against an average of $7.2 million.
- Across the five-year window, Total Current Liabilities soared 202.71% in 2021 and sank 64.24% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $8.3 million in 2021, then climbed by 13.05% to $9.3 million in 2022, then grew by 8.81% to $10.2 million in 2023, then sank by 64.24% to $3.6 million in 2024, then jumped by 70.43% to $6.2 million in 2025.
- Per Business Quant, the three latest AKAN Total Current Liabilities figures stand at $6.2 million (Q4 2025), $2.8 million (Q2 2025), and $3.6 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 6.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.20 Mn |
| Jun 30, 2025 | 2.84 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Dec 31, 2023 | 10.17 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Jun 30, 2022 | 6.27 Mn |
| Dec 31, 2021 | 8.27 Mn |
| Dec 31, 2020 | 2.73 Mn |